Introduction
============

Replication of the genome is a fundamental and carefully controlled process shared by all organisms. Given the size of the genomes, the complexity of DNA replication and its interplay with other DNA transactions such as transcription, recombination and repair, the integrity of the genome is often undermined by replication stress ([@b30]). Both endogenous and exogenous damage during DNA replication can severely impede replication. Electron microscopy and measurements of the amount and size of newly synthesized DNA have revealed that upon DNA damage unreplicated single-stranded gaps are left behind after the completion of bulk chromosomal replication ([@b45]). To cope with stalled replication forks and filling DNA gaps, cells have evolved a DNA damage tolerance (DDT) pathway that ensures replication completion. It is still unclear if DDT mechanisms operate predominantly at the stalled fork or single-stranded gaps. In addition, the pathway choice can be determined by the type of lesions and could be organism specific, since important differences have been found after treatments with various damaging agents and between vertebrates and yeasts ([@b14]; [@b31]). Recent detailed studies in yeast have provided evidence that DDT can operate effectively even after chromosomal replication ([@b12]; [@b33]) underlining the importance of gap filling. Gap filling can either take place on stalled forks that have escaped S phase or after fork collapse via D-loop formation followed by repriming. At least three separable mechanisms have been proposed to rescue stalled forks or filling-in single-stranded gaps formed opposite DNA lesions. Two of them depend on the *RAD6/RAD18*-mediated ubiquitin conjugation system, whereas homologous recombination (HR) mediates the third mechanism. The first *RAD6/RAD18* pathway directs damage bypass by translesion synthesis (TLS) polymerases to evade damaged DNA in an error-free or error-prone manner ([@b51]; [@b32]; [@b61], [@b62]). The second *RAD6/RAD18*-dependent pathway promotes a *RAD5*-mediated template switch (TS), in which the newly synthesized strand of the sister strand is used as a template ([@b76]; [@b5]). The third pathway that rescues stalled replication forks includes the *RAD52* epistasis group and utilizes the sister chromatid to achieve recombinational repair ([@b84]; [@b20]; [@b66]; [@b37]).

PCNA has been identified as a molecular switch that regulates DDT ([@b80]; [@b34]). It is a homotrimeric ring-like protein that encircles DNA and functions as a sliding clamp on the DNA ([@b40]; [@b75]; [@b22]; [@b83]) and ensures the processivity of the replicative DNA polymerases ([@b63]; [@b34]). The regulatory role of PCNA depends on post-translational modifications reflecting the DNA damage status during replication ([@b27]; [@b23]; [@b57]). Blocked DNA synthesis triggers PCNA ubiquitination. Rad18 monoubiquitinates PCNA (Ub-PCNA) on residue K164, thus activating TLS ([@b27]). Furthermore, the *RAD5*-dependent post-replication repair (PRR) mechanism is responsible for the polyubiquitination of PCNA (polyUb-PCNA) on residue K164 leading to TS. The other major post-translational modification of PCNA is SUMOylation that occurs during S phase even in the absence of exogenous damage and results in modifications at residues K164 and K127 ([@b27]). The residue K164 is the major SUMOylated site of PCNA *in vivo* and its modification depends mostly on the Siz1 E3 SUMO ligase ([@b57]; [@b81]). In yeast, it has been demonstrated that the foremost role of K164-SUMOylated PCNA (S-PCNA) is to recruit Srs2 to the replication fork ([@b54]; [@b57]). This is also the case in humans where PARI, a recently identified orthologue of Srs2, shares similar properties ([@b50]). This recruitment is believed to target the Srs2 antirecombinase activity to replication forks to prevent untimely HR that can trigger gross chromosomal rearrangements, cell-cycle arrest and cell death ([@b17]; [@b71]; [@b47]).

Srs2 is a DNA repair enzyme with ssDNA-dependent ATPase activity and a 3′ to 5′ helicase activity ([@b65]; [@b78]; [@b47], [@b48]) and the *SRS2* gene was first identified as a suppressor of *RAD6*, the ubiquitin-conjugating enzyme (E2) involved in PRR. It was suggested to play role as an antirecombinase by preventing HR via channelling the lesion into the PRR pathway ([@b67]). This has been biochemically confirmed, as Srs2 was shown to efficiently dismantle the Rad51-presynaptic filament ([@b39]; [@b79]). In addition, Srs2 can translocate on ssDNA and physically interact with Rad51 protein ([@b38]; [@b1]). These activities are essential for the Srs2 antirecombinase function ([@b38]; [@b11]; [@b69]). In fact, the interaction with Rad51 seems to not only target Srs2 to HR intermediates but also trigger ATP hydrolysis within the Rad51 filament to allow its coordinated disruption by Srs2 ([@b1]). In addition, Srs2 possesses a non-canonical PIP box requiring tandem receptor motifs for precise recognition of S-PCNA ([@b2]; [@b35]; [@b36]).

S-PCNA has the ability to recruit Srs2 to sites of replication where it can disrupt untimely formed Rad51 filaments and thus prevent HR. However, it is not known whether Srs2 or S-PCNA play further roles when replication stalls. In addition, the nature of the recombination events that are suppressed by S-PCNA and Srs2 remains elusive. Here, we report a novel mechanism by which S-PCNA together with Srs2 can block the extension of a recombination intermediate and limit its resolution associated with a crossing-over (CO). This activity requires the SUMO interaction motif (SIM) at the C-terminus of Srs2, but needs neither its translocase/helicase activity nor its interaction with Rad51. The molecular characterization of the underlying mechanism revealed that Srs2 interaction with S-PCNA dissociates Polδ or Polη from the repair synthesis ensemble. It does not affect Srs2 helicase or antirecombinase activities and represents a novel regulatory element controlling spontaneous genome rearrangements. Our results strongly support that cycling cells use the Siz1-dependent SUMOylation of PCNA to concentrate Srs2 at harmed replication forks, therefore limiting the extent of repair synthesis during TS or HR and downregulating reciprocal exchanges to maintain genome stability.

Results
=======

Srs2 inhibits the DNA polymerase activity of Polδ in a D-loop extension assay
-----------------------------------------------------------------------------

To address the biological functions of S-PCNA, we carried out *in vitro* SUMOylation of yeast PCNA on lysine residue 164 (K164). The K164-S-PCNA was purified from an enzymatic reaction as described in the experimental procedures and a fraction containing only monomers of S-PCNA was used ([Figure 1A](#f1){ref-type="fig"}). First, we tested the effect of S-PCNA on the DNA polymerase activity of Polη, a distributive TLS enzyme, as well as of the processive Polδ enzyme involved in repair synthesis ([@b46]; [@b43]). Purified S-PCNA and unmodified PCNA were loaded on an oligonucleotide-based DNA substrate by the RFC complex and the effect on DNA primer extension was assessed. Under the same reaction conditions PCNA and S-PCNA stimulate the polymerase activity of both Polη and Polδ to the same extent ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}, compare lanes 4--10 and 14--20, respectively).

The early steps of the Rad51-dependent rescue of a stalled replication fork include the formation of a D-loop structure and its extension. Therefore, we have tested the effects of PCNA, S-PCNA and Ub-PCNA on primer extension of a reconstituted plasmid-based D-loop DNA substrate ([Figure 1B](#f1){ref-type="fig"}; [@b68]). In this assay, PCNA, S-PCNA and Ub-PCNA stimulate equally well the Polδ-mediated D-loop extension ([Figure 1C](#f1){ref-type="fig"}, compare lanes 4--7, 8--11 and 12--15), indicating that PCNA stimulates the primer extension activity of Polδ regardless of the post-translational modification tested.

Since Srs2 was shown to interact with S-PCNA and to promote the synthesis-dependent strand annealing (SDSA) pathway ([@b29]; [@b64]), we wanted to test the effect of Srs2 interaction with S-PCNA on D-loop extension. The addition of increasing amounts of Srs2 results in at most a minor inhibition of the primer extension by Polδ in the presence of PCNA or Ub-PCNA ([Figure 1D](#f1){ref-type="fig"}, compare lanes 5--8 and 13--16). However, addition of Srs2 in equimolar amounts to S-PCNA results in a five-fold reduction of D-loop extension ([Figure 1D](#f1){ref-type="fig"}, lanes 7, 11 and 15), and further addition of Srs2 in the presence of S-PCNA leads to the complete abrogation of the primer extension by Polδ ([Figure 1D](#f1){ref-type="fig"}, compare lanes 5--8, 9--12 and 13--16). The inhibition is efficient compared to that observed with unmodified PCNA and correlates with the fact that Srs2 binds S-PCNA with higher affinity than the other forms ([@b54]; [@b57]; [@b9]; [@b2]).

To further underline the specificity towards S-PCNA in mediating the Srs2 inhibition, we tested whether the enzymatic removal of SUMO from PCNA will have any effect on D-loop extension. Hence, we have incubated the reaction mixture containing S-PCNA, Srs2 and Polδ with increasing concentrations of Ulp1, which mediates PCNA deSUMOylation ([@b55]). After 5 min incubation with Ulp1, the DNA polymerase reaction was started. As expected, the Ulp1-mediated removal of SUMO from PCNA restores the primer extension activity of Polδ ([Figure 1E](#f1){ref-type="fig"}, compare lanes 6--10). This result indicates that the inhibition of D-loop extension by Srs2 depends on its increased local concentration by S-PCNA.

The Srs2 SUMO interacting motif is required for Polδ inhibition
---------------------------------------------------------------

The last five amino acids of Srs2 form a SUMO interacting motif (SIM) and are crucial for the interaction with S-PCNA ([@b57]; [@b41]; [@b9]). To determine whether this SIM is required for the inhibition of D-loop primer extension, we have tested the effect of a truncated Srs2 protein lacking the last five amino acids ([Figure 2A](#f2){ref-type="fig"}). In contrast to full-length protein, this truncation does not show an inhibition of D-loop extension in the presence of S-PCNA ([Figure 2B](#f2){ref-type="fig"}, compare lanes 7--9, and 10--12, respectively). To demonstrate that the Srs2 truncation is deficient only in binding S-PCNA, we have tested it for all known biochemical activities. This truncated Srs2 preserves DNA binding, ATPase and helicase activities as well as the ability to displace Rad51 protein form the presynaptic filament, indicating that its biochemical properties analysed are indistinguishable from those of full-length Srs2 protein ([Supplementary Figures S2A and B](#S1){ref-type="supplementary-material"}). Similarly to full-length protein, the Srs2 truncation had a slight effect on the D-loop extension in the presence of unmodified PCNA ([Supplementary Figure S2C](#S1){ref-type="supplementary-material"}), compare lanes 7--9 and 10--12, respectively). Finally, we tried to suppress the Srs2 inhibitory activity by competing it out with increasing amounts of free unconjugated SUMO. This addition has no effect on D-loop synthesis and cannot alleviate the inhibitory effect of Srs2 mediated by S-PCNA ([Supplementary Figure S2D](#S1){ref-type="supplementary-material"}), therefore confirming the specific role of S-PCNA binding to Srs2.

Srs2 possesses DNA helicase activity and is capable of dislodging Rad51 from the presynaptic filament; thus, we have tested the effect of the Srs2-K41A mutant deficient in ATPase and translocase activities ([@b38]). Surprisingly, the K41A mutant is as competent as wild-type Srs2 in inhibiting D-loop extension ([Figure 2C](#f2){ref-type="fig"}, compare lanes 7--9 and 10--12, respectively), indicating that the helicase and/or translocase activities of Srs2 are not required for this inhibition. We next analysed whether Srs2 directly inhibits D-loop extension using a labelled oligonucleotide. The analysis of the products by denaturing gels confirms that the extent of DNA synthesis decreases with increasing concentrations of Srs2 ([Supplementary Figure S3](#S1){ref-type="supplementary-material"}).

To rule out the possibility that Srs2 inhibits DNA synthesis by unwinding the D-loops, we have performed the experiment using a radioactively labelled oligonucleotide. As indicated in [Supplementary Figure S4A](#S1){ref-type="supplementary-material"} and our previous publication ([@b68]), Srs2 does not unwind the D-loop, indicating that the inhibition is mediated by a protein--protein interaction with S-PCNA.

We have shown previously that the region 875--902 of Srs2 is responsible for the interaction with Rad51 ([@b11]). In our experimental system, the Srs2 875Δ902 mutant is fully capable to inhibit the extension of the D-loop by Polδ in the presence of S-PCNA ([Figure 2D](#f2){ref-type="fig"}, lanes 8--10). The extent of inhibition is almost identical to that of a wild-type protein ([Figure 2D](#f2){ref-type="fig"}, lanes 5--7), suggesting that the Rad51 interaction domain is not required for this inhibition. This is further supported by replacement of Rad51 and Rad54 by RecA protein in the D-loop formation. In the RecA-mediated D-loop DNA substrate, we observe the same extent of inhibition as detected using a Rad51-based D-loop, indicating that the strand extension inhibition is independent of Rad51 and Rad54 proteins ([Supplementary Figure S4B](#S1){ref-type="supplementary-material"}, compare lanes 4--7 to lanes 11--14). To further narrow down the region required for blocking the extension reaction, we tested a set of N-terminally truncated versions of Srs2 ([Figures 2A and E](#f2){ref-type="fig"}). Similarly to the full-length protein, most of the Srs2 fragments inhibit D-loop extension. Specifically, even the Srs2 fragment spanning residues 906--1174 and lacking the Rad51 interacting domain is fully capable of mediating the S-PCNA-dependent inhibition ([Figure 2E](#f2){ref-type="fig"}, lanes 12 and 13). On the other hand, the shorter truncation fragment of Srs2 (998--1174) no longer sustains the inhibitory effect ([Figure 2E](#f2){ref-type="fig"}, lanes 14 and 15), a result that could reflect the loss of an additional interaction site or of a proper conformation.

S-PCNA does not affect the Srs2 activities and forms a complex with Srs2
------------------------------------------------------------------------

To address whether S-PCNA influences known Srs2 biochemical activities, we tested its helicase activity in the presence of PCNA or S-PCNA. As shown in [Supplementary Figure S4C](#S1){ref-type="supplementary-material"}, neither PCNA nor S-PCNA has any effect on the ability of Srs2 to unwind 3′ overhangs. Similarly, PCNA or S-PCNA did not alter the ability of Srs2 to displace Rad51 from a nucleoprotein filament ([Supplementary Figure S4D](#S1){ref-type="supplementary-material"}). However, this displacement of Rad51 is titrated out by increasing amounts of DNA molecules loaded with S-PCNA before the addition of Srs2. This result suggests that the interaction of Srs2 with S-PCNA loaded onto a separate DNA molecule can compete out the capacity of Srs2 to dislodge Rad51 ([Supplementary Figure S4E](#S1){ref-type="supplementary-material"}). Furthermore, this suppression is stoichiometric since equimolar amounts of S-PCNA were sufficient to reduce by half the inhibitory effect of Srs2 on D-loop formation ([Supplementary Figure S4E](#S1){ref-type="supplementary-material"}, compare lanes 1 and 5). This is in agreement with a pull-down experiment showing that Srs2 can bind simultaneously Rad51 and either PCNA or S-PCNA ([Supplementary Figure S4F](#S1){ref-type="supplementary-material"}).

To gain further insight into the mechanism of the Srs2 and S-PCNA mediated inhibition, we tested the effect of Srs2 addition at different stages of the D-loop extension assay ([Supplementary Figure S5](#S1){ref-type="supplementary-material"}). First, Srs2 was added together with Polδ and S-PCNA, (Stage I). Alternatively, Srs2 was added 5 min after Polδ or at the same time when dNTPs start the extension reaction (Stages II and III, respectively). Srs2 exhibits a similar inhibitory effect on the extension reaction regardless of the order of addition ([Supplementary Figure S5](#S1){ref-type="supplementary-material"}, compare lanes 5--8, 9--12 and 13--16), indicating that S-PCNA and Srs2 readily form an elongation inhibitory complex.

PCNA SUMOylation triggers the disassembly of Polδ/PCNA complex by Srs2
----------------------------------------------------------------------

To test the possible mechanisms by which Srs2 inhibits D-loop-mediated strand extension, we monitored the amount of the free Polδ in the reaction. A three-fold molar excess of S-PCNA over Polδ was used in order to ensure that all Polδ molecules are in a complex with S-PCNA. This is indeed the case, since the addition of increasing amounts of unmodified PCNA to the reaction does not further increase D-loop extension in the absence of Srs2 ([Figure 3A](#f3){ref-type="fig"}, lanes 4--7). On the other hand, in the presence of Srs2, the addition of unmodified PCNA reverses the blockage of D-loop extension ([Figure 3A](#f3){ref-type="fig"}, lanes 8--11), indicating that Srs2 triggers the release of Polδ from the complex with S-PCNA.

To confirm that Srs2 interaction with S-PCNA is capable of releasing Polδ from the DNA polymerizing complex, we used a pull-down assay. We immobilized S-PCNA on Ni-NTA beads via a His tag on PCNA and tested the effect of Srs2 (902--1174) on the ability of Polδ to interact with S-PCNA. The addition of Srs2 to the reaction mixture containing Polδ resulted in the disruption of the interaction between Polδ and S-PCNA ([Figure 3B](#f3){ref-type="fig"}). Alternatively, we carried out the experiment with the full-length Srs2. We immobilized the S-PCNA/Polδ complex on GTH-beads via a GST tag present on the Pol3 subunit of Polδ ([Supplementary Figure S6](#S1){ref-type="supplementary-material"}, lane 7) and challenged the complex by addition of increasing amounts of Srs2 protein. As expected, the addition of Srs2 to the reaction mixture results in the disruption of the interaction between Polδ and S-PCNA and the release of S-PCNA from beads ([Supplementary Figure S6](#S1){ref-type="supplementary-material"}, compare lanes 7, 9 and 11), further supporting the Srs2 inhibition of D-loop extension by disrupting the Polδ/S-PCNA complex.

The interaction between Srs2 and S-PCNA is responsible for the sensitivity of rad18Δ cells
------------------------------------------------------------------------------------------

To determine the relative importance of Srs2 binding to Rad51, its translocase activity and its capacity to disrupt the interaction between the polymerase and S-PCNA during the rescue of stalled replication forks, we have tested the ability of different *srs2* mutants to suppress the UV sensitivity of the PRR-deficient *rad18*Δ mutants. We have used the *srs2-K41A* and *srs2-K41R* mutants deficient for their helicase activity, the *srs2 875*Δ*902* mutant that no longer interacts with Rad51 as well as the *srs2-R1* allele that abolishes the interaction with S-PCNA. Unexpectedly, the *srs2-K41A*, *srs2-K41R* and *srs2 875*Δ*902* mutants fail to suppress the rad18 sensitivity to UV irradiation, indicating that the sensitivity of *rad18*Δ mutants is not a consequence of preventing recombinational repair ([Figure 4](#f4){ref-type="fig"}). Interestingly, *srs2-R1* and *srs2*Δ are the only tested alleles of *SRS2* that partially suppress the sensitivity of *rad18*Δ mutants to UV ([Figure 4](#f4){ref-type="fig"}). These data are in agreement with previously published observations ([@b11]) in which *srs2*Δ, *srs2 (1--860)*, *srs2*Δ*PIP* or *srs2*Δ*SIM* but not *srs2 875*Δ*902* was able to suppress the *rad18*Δ sensitivity ([@b11]; [@b2]; [@b36]).

It is therefore the ability of Srs2 to disrupt the interaction between the polymerase and S-PCNA in a context where PCNA cannot be ubiquitinated that is responsible for the sensitivity of *rad18*Δ cells. This result also suggests that in the absence of the Rad18-dependent ubiquitination, maintenance of S-PCNA may prevent the TLS rescue of the stalled replication fork by recruiting Srs2.

PCNA SUMOylation is required for genome stability
-------------------------------------------------

To address the biological significance of the disruption of the S-PCNA/Polδ complex in the context of a D-loop extension, we reasoned that it should reduce the length of the repair tracts during either TS or recombinational repair (HR). A known outcome of longer repair synthesis tracts is their more often association with reciprocal exchanges and genetic instability ([@b28]). Because reciprocal exchanges involving sister chromatids cannot be measured genetically, we tested this idea using an assay measuring reciprocal exchanges between two mutant alleles of a gene, one located at its native locus while the other is inserted at an ectopic locus in an orientation that allows the recovery of reciprocal translocations ([Figure 5A](#f5){ref-type="fig"}; [@b64]). Using this system, we have shown previously that the absence of the SIM within Srs2 (*Srs2-R1* mutant) indeed leads to an elevated percentage of reciprocal exchanges between non-allelic homologous sequences in unchallenged cycling cells ([@b41]). However, the percentage of COs was lower than that monitored in the absence of Srs2. Therefore, if the CO levels observed in *Srs2-R1* mutants correspond to the fraction triggered by the interaction with S-PCNA, we should mimic this result in strains in which PCNA is not SUMOylated, that is, cells lacking the E3 ligase Siz1 responsible for most of the SUMOylation of PCNA ([@b27]) or alternatively in cells containing mutations of PCNA that prevent the modification of the major SUMOylated lysine residues (K127R and K164R, *pol30RR*). To test this prediction, we constructed isogenic strains carrying either the *siz1*Δ*::HIS3MX6* or the *pol30RR* mutations and measured the spontaneous CO levels. We found that *srs2-R1* yields CO levels that are undistinguishable from those measured in either *siz1*Δ or *pol30RR* strains. Furthermore, the combination of *srs2-R1* with *siz1*Δ, *pol30RR* or both does not lead to any further increase in the level of COs ([Figure 5B](#f5){ref-type="fig"}). Our observation strongly suggests that these mutations inactivate the same pathway and that unchallenged cells use the Siz1-dependent SUMOylation of PCNA to regulate genome stability by recruiting and concentrating Srs2 to D-loop structures. Importantly, the absence of Srs2 alone leads to elevated levels of genome instability that are not reduced by *siz1*Δ, *pol30RR* or both confirming that Srs2 prevents genome rearrangements in both a S-PCNA-dependent and independent fashion ([Figure 5B](#f5){ref-type="fig"}; [@b41]). The S-PCNA-independent pathway could involve the Srs2 helicase activity, since the elevated levels observed in the null mutant are the sum of the combined defects of both the helicase activity and the ability to interact with S-PCNA ([Figure 5B](#f5){ref-type="fig"}).

Close together markers co-convert more frequently in srs2-R1 or pol30RR mutants
-------------------------------------------------------------------------------

Conversion tracts tend to co-convert closely spaced mutations. Thus, a prediction for longer conversion tracts is that fewer recombinants should be formed. We tested this idea by measuring the spontaneous rates of arginine prototroph formation between the chromosomal copy containing the *Bgl*II mutation and three centromeric plasmids in which mutations were introduced 100, 200 and 400 bp upstream of the BglII site, respectively ([Figure 6A](#f6){ref-type="fig"}). The constructs were introduced into wild type, *srs2-R1*, *pol30RR* and *srs2-K41A* backgrounds and subjected to fluctuation analyses. We found that *srs2-K41A* and *srs2-R1* exhibit elevated recombination levels compared to *pol30RR* and the wild-type control ([Figure 6B](#f6){ref-type="fig"}). However, when we monitored the recombination increase as a function of the distance from the *Bgl*II site, we found that, as predicted, *srs2-R1* and *pol30RR* exhibit a very modest increase in spontaneous recombinant formation whereas the *srs2-K41A* and the wild-type control show a similar robust increase under the same conditions ([Figure 6C](#f6){ref-type="fig"}). This result supports the idea that failure to interact with S-PCNA yields longer conversion tracts, a feature not observed in the helicase-dead mutant.

Srs2/S-PCNA interaction as a general model for extension regulation
-------------------------------------------------------------------

As is suggested by the suppression experiments, the mechanism that we have uncovered may not be restricted to DNA synthesis during D-loop extension. To test this idea, we used a standard primer extension assay and a singly primed ΦX-174 circular ssDNA. Since wild-type Srs2 can partially dismantle the primer extension assay substrate ([@b68]), we used the Srs2-K41R mutant in this experiment ([Supplementary Figure S7A](#S1){ref-type="supplementary-material"}). We found that Srs2-K41R inhibits preferentially DNA synthesis in the presence of S-PCNA ([Supplementary Figure S7A](#S1){ref-type="supplementary-material"}, compare lanes 7--10 with lanes 11--14). Similarly, Srs2 also inhibits DNA synthesis preferentially when S-PCNA is loaded on the ΦX-174 substrate ([Supplementary Figure S7B](#S1){ref-type="supplementary-material"}, compare lanes 5--8 and 9--12). Since Srs2-K41R and Srs2 (902--1174) are as proficient as wild-type Srs2 in this reaction (data not shown), we rule out the possibility that Srs2 interferes with the stability of the ΦX-174 substrate.

Next, we investigated whether the S-PCNA/Srs2 interaction is limited only to the extension by Polδ and carried out the D-loop extension assay using Polη. Since Polη does not discriminate well the incorporation of ribonucleotides and because ATP is present in the reaction, we used \[^32^-P\]-dCTP to follow the D-loop extension reaction in the presence of PCNA and S-PCNA ([Supplementary Figure S7C](#S1){ref-type="supplementary-material"}). In lower salt conditions where the extension of a D-loop by Polη is PCNA independent ([@b68]), Srs2 inhibits the Polη-dependent D-loop extension only to the level corresponding to a PCNA-independent extension ([Supplementary Figure S7D](#S1){ref-type="supplementary-material"}, lanes 4--8). However, at the physiologically higher salt conditions, Srs2 inhibits strongly the extension of the D-loop by Polη ([Supplementary Figure S7D](#S1){ref-type="supplementary-material"}, lanes 9--13). The effect is again specific for S-PCNA, since the inhibition is much weaker in the presence of unconjugated PCNA (a five-fold versus a two-fold inhibition). These experiments strengthen our view that Srs2 inhibits DNA extension by interfering with the interaction between S-PCNA and a polymerase.

Discussion
==========

Collision of the replication fork with other machineries, exogenously induced damage or proteins tightly associated with DNA is thought to occur frequently in cycling cells. Such events can cause serious threats to the cells and need to be quickly detected and efficiently repaired to preserve genome integrity ([@b19]). PCNA acts as a molecular switch that controls how DNA lesions are processed during replication. In the presence of DNA damage, PCNA is modified at the conserved lysine residue 164 by either mono-ubiquitin or a lysine-63-linked poly-ubiquitin chain, which induce error-prone or error-free replication bypass of the lesions, respectively ([@b27]). PCNA can also undergo SUMOylation during replication in the absence of DNA damage ([@b27]), a modification that contributes to the recruitment of the Srs2 helicase to the replication fork to prevent untimely recombination during S phase ([@b54]; [@b57]). However, our current understanding of how S-PCNA-dependent recruitment of Srs2 results in decreased levels of recombination at replication forks is not clear. In this study, we have investigated the biochemical and biological consequences of PCNA SUMOylation and have uncovered a novel molecular mechanism that can modulate DNA repair and recombination at stressed replication forks and thus limits genome instability.

S-PCNA does not prevent polymerase activity
-------------------------------------------

Since PCNA monoubiquitination promotes the recruitment of TLS polymerases ([@b27]), we analysed the influence of post-translational modifications of PCNA on the DNA synthesis activity of replicative and TLS polymerases. S-PCNA indeed stimulates the polymerase activity of both Polδ and Polη, but only to an extent similar to that reported for unmodified or ubiquitinated PCNA ([@b24]), indicating that the presence of ubiquitin or SUMO residues on PCNA does not affect significantly the competence of DNA polymerases to elongate a linear template. Since S-PCNA recruits the Srs2 antirecombinase to the replication fork where it could regulate HR ([@b18]; [@b39]; [@b79]), we tested the direct effect of S-PCNA on a recombination reaction. However, since previous findings have indicated that the canonical antirecombination activity of Srs2 is independent of its interaction with S-PCNA ([@b41]), we did not expect to find a strong effect of S-PCNA on the ability of Srs2 to dismantle Rad51 filaments. Indeed, we detected normal removal of Rad51 by Srs2 in the presence of PCNA or S-PCNA. Concomitantly, when we loaded S-PCNA on streptavidin-biotin blocked DNA substrates we observed a decrease in the ability of Srs2 to dismantle Rad51 protein from ssDNA, most probably due to a titration of Srs2 by the S-PCNA-loaded DNA substrate. This is supported by the pull-down experiments showing that the interaction with Rad51 and PCNA is independent of each other. Therefore, S-PCNA sequesters Srs2 at a position or in a state that outcompetes the interaction with Rad51. Altogether this indicates that recruiting Srs2 to replication forks could serve yet another purpose in the HR process.

Specific S-PCNA interaction with Srs2 leads to the inhibition of repair synthesis
---------------------------------------------------------------------------------

Since D-loop formation and its extension is a prerequisite for the Rad51-dependent fork rescue and because the TS mechanism shares similarities with HR ([@b26]; [@b21]), we expected the Srs2/S-PCNA complex to inhibit repair synthesis. The D-loop reaction linked with primer extension ([@b68]) is insensitive to the presence of unmodified or ubiquitinated PCNA. On the contrary, under the same conditions, the Srs2 protein fully inhibits D-loop extension in the presence of S-PCNA. This observation indicates that, rather than displacing Rad51 filaments, targeting Srs2 to the fork through PCNA SUMOylation confers an inhibitory effect on D-loop extension. Several independent experiments further support this conclusion. First, introduction of the deSUMOylating enzyme Ulp1 into the reaction mixture restores the extension by Polδ. Second, an Srs2 protein missing its SIM loses the ability to inhibit the D-loop extension reaction, indicating a requirement for direct protein--protein interaction between Srs2 and S-PCNA. Third, the ability of Srs2 to dismantle Rad51 filaments might not be essential during the rescue of stalled replication forks since the interaction of Srs2 with S-PCNA is dispensable for this activity ([@b41]). Fourth, our data show that the helicase activity and ability to interact with Rad51, the hallmark of antirecombinase activity ([@b38]; [@b1]; [@b11]), are neither required for the inhibitory effect observed in the D-loop extension assay nor involved in the suppression of the sensitivity to UV of a *RAD18* deletion. This also explains the findings of a previous genetic screen for suppressors of *rad18*Δ UV sensitivity ([@b53]). Two classes of *srs2* alleles have been described, one of which affects recombination. Interestingly, out of the five alleles suppressing the UV sensitivity, four are located outside the helicase domain, farthermost at the C-terminus of the protein that we show to be responsible for the inhibitory effect on DNA extension ([@b53]). Fifth, since Srs2 is capable of inhibiting RecA-mediated D-loop extension, the Srs2 inhibition is independent of the interaction with Rad51 and Rad54.

Srs2 disrupts S-PCNA/Polδ elongation complex
--------------------------------------------

A possible mechanism by which Srs2 mediates the inhibition of DNA synthesis could be by disrupting the interaction between Polδ and S-PCNA. In agreement with this hypothesis, addition of saturating concentrations of unmodified PCNA to the reaction relieves the Srs2 inhibition, allowing free Polδ to engage in de novo DNA synthesis, a result confirmed by pull-down experiments with purified proteins. This observation suggests that the interaction of Srs2 with S-PCNA could affect the accessibility of the interdomain connector loop (IDCL) of PCNA ([@b15]). The IDCL serves as an interaction surface of the PIP box containing proteins and hence could also affect the binding of PCNA to other proteins through this motif. Indeed, Srs2 does not only inhibit Polδ, the DNA polymerase involved during repair synthesis ([@b46]; [@b43]; [@b8]), but also specifically inhibits extension of S-PCNA/Polη complex, indicating that this regulatory mechanism could be more general.

Model of stalled fork repair
----------------------------

Based on genetic evidence, several models for repair of stalled replication forks have been proposed ([@b77]). The data presented here extend these models in several ways and put forward a possible molecular mechanism for the role of S-PCNA and Srs2 during replication. It is widely accepted that PCNA and its post-translational modifications serve as a molecular switch that can regulate the processing of stalled or collapsed replication forks. Under undisturbed conditions, both PCNA and S-PCNA stimulate the processivity of the replicative DNA polymerases. We do not know the nature of the signal that triggers PCNA SUMOylation during S phase, however in the presence of DNA damage, PCNA undergoes mono- or poly-ubiquitination ([@b27]; [@b76]; [@b23]). Mono-ubiquitination of PCNA on residue K164 directly promotes the Rad18-dependent damage tolerance repair pathway ([@b23]). In addition, polyubiquitination of PCNA results in error-free damage tolerance mediated by Rad5-dependent TS/gap repair mechanism ([@b5]; [@b7]; [@b77]). On the other hand, SUMOylation of PCNA on residues K164 and K127 also promotes replication through damaged DNA, and targets Srs2 to the replication fork to downregulate the HR pathway ([@b54]; [@b57]). However, in light of several recent observations, we believe that the ability of Srs2 to dismantle the Rad51 filament might be required preferentially at recombination foci rather than at replication forks since this activity is not dependent on the interaction with S-PCNA ([@b41]; [@b9]). In addition, it has been shown that both Rad18/Rad5 and Rad51-dependent pathways promote the formation of X-shaped structures that resemble pseudo double Holliday junctions at damaged replication forks ([@b44]; [@b6]; [@b49]). Furthermore, Rad18 and Rad51 cooperate to promote TS and the Ubc9-dependent SUMOylation pathway regulates this cooperation ([@b7]). Interestingly, the Rad51 recombinase is important for proper replication in Xenopus extracts and is required for the formation of intermediates that accumulate in *rad5* and *rad18* mutants during the repair of stalled or collapsed replication forks ([@b58]; [@b25]). Our data also show that interaction of Srs2 with S-PCNA can outcompete the interaction with Rad51 and thus limit the ability of Srs2 to dismantle the filament. In such a scenario, S-PCNA targets Srs2 to the stalled fork and limits the extent of Rad51-dependent repair synthesis by releasing Polδ from its complex with S-PCNA, thus blocking the further extension of the 3′ end of the invading primer strand and limiting the extent of conversion ([Figures 6](#f6){ref-type="fig"} and [7](#f7){ref-type="fig"}). Since CO formation is more dependent on homology length than gene conversion ([@b28]; [@b59]) shorter DNA repair stretches keep reciprocal exchanges at a low level. Indeed, as PCNA becomes increasingly SUMOylated, Srs2 turns out to be gradually concentrated at D-loops where it can block the extension of repair synthesis, providing a mechanism limiting the extent of conversion tracts. As proposed earlier ([@b29]; [@b64]), Srs2 promotes SDSA and limits the occurrence of potentially harmful COs, but the direct molecular mode of action is not clear. First, Srs2 can promote SDSA by blocking second end capture. Alternatively, Srs2 could directly unwind D-loops ([@b13]) or promote an even more efficient D-loop unwinding by targeting the efficient Mph1 helicase ([@b60]; [@b68]). Finally, through its direct interaction Srs2 could also mark/target the D-loop for an effective dissolution by Sgs1 or further processing by the Mus81/Mms4 proteins ([@b18]; [@b10]; [@b64]; LK, unpublished data).

Siz1 is required for genomic stability during S phase
-----------------------------------------------------

The association of Srs2 with recombination foci seems to be S-PCNA independent ([@b9]). This is also supported by the observation that deletion of *SIZ1* does not affect the elimination of toxic intermediates ([@b74]; [@b57]). However, we confirm that Siz1 is required for genome stability ([@b82]; [@b52]). In its absence, ectopic recombination intermediates formed spontaneously in the cell are no longer resolved with a strong bias towards non-COs (NCOs), a result similar to that observed when both lysine residues of PCNA (*pol30RR*) that can become SUMOylated are replaced by arginine residues. This result strongly argues that the effect on genome stability in unchallenged cells is mediated principally through PCNA SUMOylation, since the absence of the ubiquitination pathway has no effect on the resolution of recombination intermediates either by itself or in a *siz1* and *pol30RR* background (SG, unpublished results). Because the formation of a CO following a DSB induced out of S phase is not affected by the absence of components associated with replication forks ([Supplementary Figure S8](#S1){ref-type="supplementary-material"}), we believe that during S-phase S-PCNA actively prevents the formation of double Holliday junctions and their resolution by inhibiting or terminating the extension of the D-loop. Because they can lead to loss of heterozygosity and chromosomal aberrations, COs are potentially dangerous intermediates that occur much less frequently in mitotic than in meiotic cells ([@b16]; [@b4]; [@b73]). Indeed, COs have been associated with many human disorders ([@b70]) supporting the need for tight regulation and control. In yeast, at least three mechanisms characterized by three different helicases, Srs2, Sgs1 and Mph1, can operate to suppress CO formation ([@b60]; [@b47]).

In summary, our findings provide a novel insight into the mechanism by which S-PCNA/Srs2 complex may operate in the rescue of a stalled replication fork. While PCNA acts as a molecular switch responsible for engaging the cell into a given repair pathway through various post-translational modifications, Srs2 acts as a molecular caretaker that efficiently transduces PCNA signalling. Together with S-PCNA, Srs2 is an additional control point in the fork rescue mechanism providing flexibility by limiting the amount of toxic DNA structures and promoting the gap-filling/TS function of Rad18-Rad5 through reversible recombination intermediates ([@b7]).

Yet, such a mechanism involving S-PCNA and Srs2 can become toxic for the cells under certain circumstances. Indeed, the overproduction of either Srs2 or its helicase-dead variant results in a synthetic lethal phenotype in combination with many replication-associated genes, an activity that depends on the S-PCNA interaction motif ([@b42]), and emphasizes the need for the S-PCNA-mediated activity to be under a very tight control. Accordingly, it has recently been reported that in the absence of Elg1, an alternative subunit of the RFC clamp loader that interacts preferentially with S-PCNA, both Srs2 and S-PCNA accumulate on chromatin ([@b56]). This raises the possibility for a role of Elg1 in unloading S-PCNA from DNA after the completion of a repair event in unchallenged cells, an intriguing mechanism to address in future studies. Finally, it will be extremely interesting to determine whether PARI or other human translocases behave like Srs2 in a reconstituted DNA synthesis assay with human S-PCNA.

Materials and methods
=====================

PCNA SUMOylation and purification of S-PCNA
-------------------------------------------

In vitro SUMOylation reaction of PCNA was carried out in 2 ml of P0 buffer (40 mM Tris--HCl pH 7.5; 8 mM MgCl~2~; 100 μg/ml BSA; 10% glycerol; 100 μM ATP) in the presence of PCNA (40 μg), GST-Aos1 (30 μg), GST-Uba2 (30 μg), GST-Ubc9 (30 μg), GST-Siz1 (1--465) (90 μg), Smt3-GG (600 μg), RFC (4 μg), DNA (50 μg) for 2 h at 30°C.

The crude PCNA and S-PCNA containing reaction mixture has been applied to a 1-ml MonoQ 5/50 column (GE Healthcare) and extensively washed with buffer A (70 mM NaCl, 40 mM Tris--HCl pH 7.5, 0.01% Nonidet P-40, 10% glycerol). Reaction enzymes have been washed out with a 3-ml gradient to 33% of buffer B (1 M NaCl, 40 mM Tris--HCl pH 7.5, 0.01% Nonidet P-40, 10% glycerol). S-PCNA has been eluted with a 5-ml gradient of buffer B from 33 to 50%. The S-PCNA containing fractions have been pooled, diluted and concentrated using a 200-μl MiniQ PC3.2 column by eluting the S-PCNA with a 3-ml gradient to 100% of buffer B. Peak fractions have been collected and used directly in subsequent assays. Mass spectrometry analysis revealed that 95% of PCNA SUMOylation is found on K164 and 5% on K127. Ub-PCNA was purified as described previously ([@b24]).

D-loop extension assay
----------------------

The D-loop assay was performed essentially as described previously ([@b38]), and the details are included in [Supplementary data](#S1){ref-type="supplementary-material"}. The primer extension reaction was assembled as described in [@b68]. Briefly, standard 30 μl reaction mixture containing 12 μl from the D-loop reaction was supplemented with 660 nM RPA, 10 nM PCNA or SUMO- or Ubiquitin-PCNA, and 33 nM Polδ in buffer O (20 mM Tris--HCl pH 7.5, 5 mM DTT, 0.1 mM EDTA, 150 mM KCl, 40 μg/ml BSA, 8 mM MgCl~2~, 5% glycerol, and 75 μM each of dGTP and dCTP). PCNA loading reaction was incubated at 30°C for 5 min. Reaction was stopped by cooling on ice followed by addition of Srs2 and other indicated proteins (Ulp1). Reaction was continued at 30°C for an additional 5 min. DNA synthesis was initiated by addition of buffer O containing 75 μM dTTP and 0375 μCi \[α-^32^P\] dATP or 75 μM. After 10 min extension at 30°C, the reactions were stopped, deproteinized and loaded onto a 0.8% (w/v) agarose gel. The gel was either directly analysed for fluorescent DNA species or dried on DE81 paper and exposed to a Phosphorimager screen and imaged in Fuji FLA 9000 imager with the Multi Gauge software (Fuji).

Recombination assays
--------------------

The determination of spontaneous CO and DSB-induced CO frequencies have been previously reported ([@b3]; [@b64]) and are described in [Supplementary data](#S1){ref-type="supplementary-material"}.

UV survival curves
------------------

Haploid strains were grown for 3 days in YEPD to saturation. Cells were serially diluted and plated on YEPD. Plates with the lids removed were exposed to the UV light source for increasing times at 0.5 J/m^2^/s. To prevent photoreactivation, exposure to the UV light source was conducted in the dark and the plates were subsequently kept in the dark following irradiation. Plates were incubated at 30°C for 2 days prior to determining cell survival. The experiments were repeated three times and the results shown for each point are the average with the standard deviation.

Determination of spontaneous recombination rates in strains harbouring a plasmid
--------------------------------------------------------------------------------

A colony from the strains to be tested was inoculated in synthetic medium lacking uracil and grown to saturation for 3 days at 30°C at 220 r.p.m. Next, the cultures were diluted to a concentration of 500 cells per ml and dispatched into twelve 2.5 ml cultures and grown to saturation for 5 days at 30°C at 220 r.p.m. The concentration of each individual culture was measured by plating out appropriate amounts of a dilution of the cultures onto synthetic medium lacking uracil. Appropriate volumes of each culture were plated onto synthetic medium lacking uracil and arginine. After 4 days at 30°C, the number of colonies were counted and subjected to a rate analysis ([@b72]).
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![Effect of S-PCNA on D-loop extension by Polδ. (**A**) Purified PCNA and S-PCNA. PCNA was SUMOylated and purified as described in the experimental procedures. (**B**) Schematic of the of the D-loop reaction linked with primer extension using a plasmid-based DNA substrate. (**C**) D-loop extension in the presence of PCNA, Ub-PCNA and S-PCNA. Rad51 (1 μM) and Rad54 (150 nM) mediated D-loops were mixed with Polδ (33 nM) and indicated amounts of PCNA, Ub-PCNA or S-PCNA in an equimolar complex with RFC, respectively. After 5 min incubation, the reaction was started with the addition of dTTP and \[^32^-P\]-dATP, followed by a 10-min extension. The reaction products were treated with proteinase K, resolved on a 0.8% agarose gel and analysed. The numbers at the bottom of the panel represent relative amounts of extension products. The percentage of incorporation is determined as an amount of incorporated dATP versus the total amount of \[^32^P\]-dATP. (**D**) Srs2-mediated inhibition of D-loop extension. Reactions were carried out as described in (**C**) except that 5 min after loading PCNA three concentrations of Srs2 (4, 20 and 100 nM) were added to the reactions. (**E**) Inhibition of D-loop extension by Srs2 requires SUMOylated PCNA. The D-loop extension reaction was performed in the presence of the D-loop substrate, RFC, Polδ, Srs2 and S-PCNA. After 5 min incubation with Srs2, increasing amounts of Ulp1 (2, 6, 12 and 20 nM) were added. Following 5 min incubation, the reactions were started with the addition of dTTP and radioactively labelled dATP. After a 10-min extension, the reactions were stopped and the products analysed. Relative extension represents an amount of incorporated \[^32^P\]-dATP in the extension products relative to the incorporation in the absence of Srs2, which was set as 100%.\
Source data for this figure is available on the online [supplementary information](#S1){ref-type="supplementary-material"} page.](emboj20139f1){#f1}

![The SIM but not the catalytic activity of the Srs2 mediates the inhibition of the D-loop extension by Polδ. (**A**) Schematic of the Srs2 domains and truncations used in this study. (**B**) D-loop extension by Polδ in the presence of S-PCNA and Srs2 or its SIM deleted truncation (Srs2 (1--1169)). Reactions were assembled as described earlier and incubated with increasing amounts of Srs2 or Srs2 (1--1169). (**C**) Inhibition of D-loop extension by Polδ is independent of the Srs2 ATPase activity. Reactions were carried out as described in the experimental procedures using wild-type Srs2 and Srs2-K41A mutant. (**D**) The inhibition is independent of the Rad51 binding site of Srs2. The Rad51 interaction-deficient mutant of the Srs2 875Δ902 inhibits the D-loop extension. Reactions were carried out as described using increasing amounts (4, 20 and 100 nM) of Srs2 and Srs2 875Δ902 proteins. (**E**) Minimal Srs2 region required for inhibition of extension. Reactions were carried in the presence of full-length Srs2 as well as Srs2 C-terminal fragments ranging from 824 to 998 until the end of the protein. The numbers at the bottom of the panels are the relative amounts of extension product representing an amount of incorporated \[^32^P\]-dATP in the extension products relative to the incorporation in the absence of Srs2, which was set as 100%.\
Source data for this figure is available on the online [supplementary information](#S1){ref-type="supplementary-material"} page.](emboj20139f2){#f2}

![Srs2 inhibits D-loop extension by disruption of the Polδ/S-PCNA interaction. (**A**) Addition of free PCNA can alleviate the inhibition of D-loop extension. Reactions were carried out as described earlier except that after 5 min incubation, indicated amounts of unmodified PCNA were added into the reaction containing S-PCNA/RFC (20 nM), Polδ (33 nM) and, where indicated, 100 nM of Srs2. Following 10 min incubation at 30°C, the reactions were treated with proteinase K and resolved on a 0.8% agarose gel. Extension products were quantified, and the percentage of relative extension is given at the bottom of the figure. (**B**) Srs2 disrupts the interaction between S-PCNA and Polδ. S-PCNA from the *in vitro* SUMOylation reaction containing both PCNA and S-PCNA (with the hexahistidine tag, 5 μg) was mixed with 5 μg of purified polymerase δ and increasing amounts of Srs2 (5 or 12.5 μg). After incubation, the beads were washed and treated with SDS to elute bound proteins. The supernatants with unbound proteins and the SDS elution were analysed by SDS--PAGE. Lanes 2, 3, 7 and 8 are controls where only Srs2 or Polδ was incubated with Ni-NTA beads. \* points at Polδ degradation products. Relative quantification of GST-Pol3 on Ni-NTA beads is indicated.\
Source data for this figure is available on the online [supplementary information](#S1){ref-type="supplementary-material"} page.](emboj20139f3){#f3}

![Suppression of the UV sensitivity of *rad18*Δ mutants by different alleles of *SRS2*. Haploid strains in a *RAD18* (filled circles, solid lines) and *rad18*Δ (filled squares, dotted lines) background were grown to stationary phase in liquid YEPD medium and exposed to UV irradiation at 0.5 J/m^2^/s as described in [Supplementary data](#S1){ref-type="supplementary-material"}. Each point on the curves is the average of three experiments.](emboj20139f4){#f4}

![Reciprocal exchange is enhanced by the loss of interaction between S-PCNA and Srs2. (**A**) Genetic system is used to determine the proportion of COs among spontaneous recombinants. Bg and RV indicate the mutation of the *Bgl*II and *Eco*RV sites that invalidate the *ARG4* genes. Note that the converted allele leading to arginine prototrophy has been arbitrarily attributed to one of the arg4 mutant copies. (**B**) Plot of the percentage of CO-associated recombination events in various mutant backgrounds. Each dot represents an experiment carried out on 156 spontaneous events. NS, not significant for *P*-values \>0.05; \*, significant at *P*-values ≤0.05.](emboj20139f5){#f5}

![*srs2-R1* and *pol30RR* reduce the spontaneous conversion rate for closely spaced mutations. (**A**) A two-kb chromosomal fragment of the *ARG4* locus was inserted into a centromeric plasmid containing the *URA3* marker. Three plasmids containing a frameshift mutation located at 100, 200 and 400 bp upstream of the *Bgl*II site were generated and transformed into wild-type, *pol30RR*, *srs2-K41A* and *srs2-R1* strains containing the *arg4*Δ*Bgl*II mutation at the *ARG4* locus. (**B**) Rates of arginine prototroph formation. (**C**) Relative effect to that observed when the mutations are 100 bp apart.](emboj20139f6){#f6}

![Schematic view of the roles of S-PCNA and Srs2 in the rescue of stalled replication forks. Left panel, monoubiquitination of PCNA on residue K164 promotes the Rad6/Rad18-dependent TLS pathway. Therefore, in the absence of Rad18 (boxed area) the cells become extremely sensitive to UV damage. On one hand, absence of ubiquitination no longer triggers the replacement of Polδ by Polη while on the other hand the unconjugated lysine K164 allows SUMOylation to recruit Srs2 that in turn dislodges either Polδ or Polη. This sensitivity is partially alleviated when Srs2 can no longer interact with S-PCNA (*srs2*Δ*SIM*). The dotted arrows indicate suboptimal processes. Right panel, polyubiquitination of PCNA results in error-free Rad5-dependent TS. Furthermore, Rad51 cooperates to promote TS regulated by the Ubc9-dependent SUMOylation pathway (TS/HR). SUMOylation of PCNA on residues K164 and K127 targets Srs2 to the replication fork to downregulate the HR pathway. As PCNA becomes increasingly SUMOylated, Srs2 is gradually concentrated at D-loops where it can block the further extension of repair synthesis and limit the extent of conversion tracts by releasing Polδ from its complex with S-PCNA. As a consequence, shorter stretches of DNA synthesis are easier to become destabilized through various activities therefore promoting NCO outcomes. Finally, Srs2 could also stimulate SDSA directly, thus lowering the risk of CO occurrence.](emboj20139f7){#f7}
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